PPSV23 immunogenicity in patients receiving Erlotinib

Dr Michal Meir Back to your profile View as PDF Research Inquiry What is the currently available data regarding PPSV23 immunogenicity in patients receiving Elortinib therapy? Patient’s Summary A 4-year-old boy underwent bone marrow transplantation one year ago as part of metastatic mesoblastic nephroma treatment, today he receives Elortinib therapy. According to his post-transplantation vaccination […]